Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–14 of 14 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +10 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
- Kaiser Permanente-Bellflower Bellflower, California, United States
NCT06589804
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +38 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Fremont - Rideout Cancer Center Marysville, California, United States
- VA Palo Alto Health Care System Palo Alto, California, United States
- UCHealth Memorial Hospital Central Colorado Springs, Colorado, United States
Recruiting
Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer
NCT04754321
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma of Unknown Primary, +11 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT06662058
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +54 more
- Locations
-
- Emory Midtown University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT07156227
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +48 more
- Locations
-
- UPMC Hillman Cancer Center LAO Pittsburgh, Pennsylvania, United States
NCT06980038
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +41 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Ochsner Medical Center Jefferson New Orleans, Louisiana, United States
NCT06868433
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +48 more
- Locations
-
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT06636734
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more
- Locations
-
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT01064479
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +29 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- MD Anderson Regional Care Center-Katy Houston, Texas, United States
- MD Anderson Regional Care Center-Bay Area Nassau Bay, Texas, United States
- MD Anderson Regional Care Center-Sugar Land Sugar Land, Texas, United States
Active, Not Recruiting
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT04862650
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
NCT00494182
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
NCT05172258
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
- City of Hope Antelope Valley Lancaster, California, United States
- Keck Medicine of USC Koreatown Los Angeles, California, United States
Active, Not Recruiting
Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
NCT03468218
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +29 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer
NCT04576091
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Northwestern University Chicago, Illinois, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States